A white matter lesion is an area of damage in the white matter of your brain, the tissue made up of nerve fibers coated in a fatty insulating layer called myelin. These lesions show up as bright spots on certain types of MRI scans, and they’re extremely common: by age 65, they’re detectable in roughly 90% of people. While a single small lesion may cause no symptoms at all, a heavier load of lesions can affect thinking, memory, and walking over time.
What White Matter Actually Does
Your brain has two main types of tissue. Gray matter contains the cell bodies of neurons, where processing happens. White matter contains the long cables (axons) that connect different brain regions, wrapped in myelin that speeds up electrical signals. Think of white matter as your brain’s wiring network. When a section of that wiring gets damaged, the affected area appears as a lesion on imaging.
The damage can involve the myelin sheath breaking down, the axons themselves being injured, or both. It can also reflect fluid accumulation around small blood vessels in the brain. The result is the same on a scan: a bright spot that tells your doctor something has disrupted the normal tissue in that area.
How They Appear on MRI
White matter lesions show up as bright white spots on two specific MRI sequences called T2 and FLAIR imaging. Radiologists sometimes call them “white matter hyperintensities” because of this bright appearance. They’re most commonly found in two locations: periventricular white matter (right next to the fluid-filled chambers in the center of your brain) and deep white matter (farther out from those chambers, often around small blood vessels).
Doctors grade the severity of these lesions using the Fazekas scale, which scores periventricular and deep lesions separately from 0 to 3. For periventricular lesions, a score of 1 means thin lines or small caps around the ventricles, 2 means a smooth halo of brightness, and 3 means irregular lesions that extend outward into the deeper white matter. For deep lesions, a score of 1 means scattered small dots, 2 means those dots are starting to merge together, and 3 means large fused areas of damage. A Fazekas score of 1 in either location is generally considered a normal part of aging.
The Most Common Causes
The single most frequent cause is small vessel disease, sometimes called microvascular ischemic disease. This happens when the tiny blood vessels supplying your white matter narrow or stiffen over time, reducing blood flow. The white matter is especially vulnerable because it sits at the far end of the brain’s blood supply, making it the first area to suffer when circulation drops.
Beyond small vessel disease, the list of possible causes is long:
- Vascular: atherosclerosis (plaque buildup in arteries), migraine, and inflammation of blood vessel walls
- Inflammatory: multiple sclerosis is the most well-known, along with related conditions like neuromyelitis optica
- Infectious: HIV, Lyme disease, and certain viral infections can damage white matter
- Toxic: chronic heavy alcohol use, carbon monoxide poisoning, and certain recreational drugs
- Metabolic: vitamin B12 deficiency and copper deficiency
- Traumatic: repeated concussions or radiation therapy to the brain
In most older adults, small vessel disease related to aging and high blood pressure is the explanation. In younger people, the same finding raises more concern and typically prompts a more thorough workup.
How MS Lesions Differ From Vascular Ones
If you’re younger or your doctor is trying to distinguish between multiple sclerosis and ordinary vascular wear, the shape and location of lesions matter a great deal. MS lesions tend to be oval-shaped and oriented perpendicular to the brain’s ventricles, following the path of deep veins. They also commonly appear in the corpus callosum (the thick band connecting the two brain hemispheres), in tissue right next to the cortex, and in the brainstem or cerebellum.
Vascular lesions from small vessel disease, by contrast, tend to be more irregular in shape and cluster in the deep white matter and periventricular zones. They rarely involve the corpus callosum, because that structure has a double blood supply that protects it from ischemic damage. Vascular lesions also tend to spare the tissue right next to the cortex. These patterns help radiologists and neurologists tell the two apart, though overlap exists.
Risk Factors You Can Control
Advanced age is the strongest predictor of white matter lesion burden, and you can’t change that. But the second strongest predictor is high blood pressure, and that you can do something about. Research in people with type 2 diabetes and high cardiovascular risk found that those who maintained a systolic blood pressure around 119 mmHg developed roughly half the new lesion volume over 40 months compared to those with a systolic pressure around 134 mmHg (0.67 vs. 1.16 cubic centimeters of new lesion growth). Uncontrolled hypertension and smoking are both consistently linked to faster lesion progression over time.
Interestingly, in that same study, tighter blood sugar control made no difference in lesion progression, suggesting that blood pressure matters far more than glucose levels for protecting white matter. A history of cardiovascular disease, prior stroke, and impaired kidney function were also associated with heavier baseline lesion burden.
Symptoms and Cognitive Effects
Many people with mild white matter lesions have no symptoms at all and only learn about them incidentally from a brain scan done for another reason, like a headache workup. This is especially true for Fazekas grade 1 lesions in older adults.
As lesion volume increases, problems tend to emerge in specific areas. Executive function (planning, organizing, switching between tasks) is often affected first. Memory deficits and psychomotor slowness, where thinking and physical reactions both take longer, are also common. Gait disturbance is a particularly well-documented effect: people with significant white matter damage may develop a slow, shuffling, or unsteady walk. Research shows these gait problems are closely linked to cognitive decline, not just physical changes in the brain’s motor pathways. The damage disrupts connections between brain regions that coordinate both movement and thinking simultaneously.
Long-Term Risks
White matter lesions aren’t just a cosmetic finding on a scan. Higher lesion volume and worse severity scores are significantly correlated with cognitive impairment over time. In stroke patients, both the total white matter lesion score and the volume of deep white matter lesions predicted cognitive decline at the one-year mark. The correlation was modest but statistically significant, meaning lesion burden is one piece of the puzzle rather than the whole picture.
The relationship between white matter lesions and dementia risk is well established in large population studies. People with heavier lesion loads face higher odds of developing vascular dementia and also appear to be at elevated risk for Alzheimer’s disease, likely because vascular damage lowers the threshold at which other brain changes become symptomatic. White matter lesions also increase the risk of future stroke, creating a cycle where vascular damage begets more vascular damage.
What Slows Progression
Existing white matter lesions can’t be reversed, but their progression can be slowed substantially. Blood pressure control is the single most impactful intervention supported by evidence. Keeping systolic blood pressure well controlled, particularly below 120 mmHg in high-risk individuals, cuts the rate of new lesion development roughly in half. Quitting smoking removes another major accelerant of white matter damage. Managing cholesterol and maintaining cardiovascular fitness protect the small vessels that supply white matter with blood and oxygen.
For lesions caused by something other than vascular disease, the approach depends entirely on the underlying condition. B12 deficiency is correctable with supplementation. MS-related lesions are managed with disease-modifying therapies that reduce new lesion formation. Toxic causes may stabilize once the exposure stops. The critical first step is always identifying why the lesions are there, which is what your doctor is working to determine when they order follow-up tests after spotting them on a scan.